April 7, 2020Novo Nordisk’s Rybelsus Nabs European ApprovalNovo Nordisk expects to launch Rybelsus in the second half of 2020.
April 7, 2020Celgene’s Reblozyl Earns FDA Approval for AnemiaReblozyl is the first approved treatment for patients with myelodysplastic syndromes in 15 years.
April 7, 2020Izana Begins Trial of Rheumatoid Arthritis Drug for COVID-19Namilumab is currently in late-stage clinical development for the treatment of rheumatoid arthritis and ankylosing spondylitis.
